Allergen-mediated disease: keeping patients active

Area of Science:

• Allergy and Immunology
• Sports Medicine
• Dermatology

Background:

• Allergic rhinitis treatment with nasal corticosteroids shows delayed efficacy, potentially reducing patient compliance.
• Allergic conjunctivitis management involves topical vasoconstrictors, cromolyn, and NSAIDs.
• Exercise-induced or exercise-exacerbated asthma in athletes may involve refractory periods and requires specific pharmacological approaches.
• Atopic dermatitis treatment primarily relies on topical steroids.

Purpose of the Study:

• To review current therapeutic strategies for common allergic conditions.
• To highlight challenges in managing allergic diseases in competitive athletes due to drug restrictions.

Main Methods:

• Literature review of established treatments for allergic rhinitis, conjunctivitis, asthma, and atopic dermatitis.
• Discussion of pharmacological options including corticosteroids, beta-2 agonists, leukotriene antagonists, and NSAIDs.
• Analysis of the impact of anti-doping regulations on therapeutic choices for athletes.

Main Results:

• Nasal corticosteroids are the most effective treatment for allergic rhinitis, despite delayed onset of action.
• Multiple agents are recommended for allergic conjunctivitis and atopic dermatitis.
• Management of exercise-induced asthma involves various inhalers and antagonists, considering potential refractory periods.
• Drug restrictions imposed by sports governing bodies significantly limit treatment options for competitive athletes.

Conclusions:

• Optimizing treatment compliance for allergic rhinitis requires addressing the delay in corticosteroid effects.
• A range of therapies are available for allergic conditions, but their application in athletes is constrained by regulations.
• Further research may be needed to develop compliant and effective treatments for allergic diseases in athletes.